Description
Melanotan II is a synthetic peptide analogue of the naturally occurring alpha-melanocyte-stimulating hormone. In biochemical research, this Melanotan II peptide compound is heavily investigated for its unique signaling efficiency. Specifically, it targets the melanocortin receptors (primarily MC1R, MC3R, and MC4R) to stimulate melanogenesis pathways. Furthermore, it operates centrally within neurochemical models without requiring direct UV exposure to trigger responses. Therefore, this high-purity Melanotan II peptide remains a core subject in laboratory studies looking at cellular pigmentation and endocrine signaling.
Verified Purity and Experimental Protocols
To support precise and replicable results across your scientific assays, our research-grade Melanotan II peptide is strictly maintained under high industry quality controls.
Purity: Hits a minimum 99% rating verified via analytical testing.
Format: Lyophilized powder to secure compound integrity and shelf-life.
Documentation: Fully backed by independent testing with a Certificate of Analysis (COA) available.
Mechanism and Research Focus
Because the Melanotan II peptide operates via widespread melanocortin receptor activation, researchers frequently utilize this compound to analyze melanin production dynamics. In addition, it helps to evaluate secondary metabolic signaling cascades. If your laboratory setup involves comparative evaluation of hormonal receptors or cellular adaptation, you can cross-examine its properties. For instance, you can analyze it alongside other synthetic sequences available in our Research Peptides Collection.
Handling and Storage
To minimize structural degradation, store the lyophilized vial at -20°C. Please protect the compound from direct light. Additionally, avoid frequent freeze-thaw cycles after reconstitution to preserve the peptide bonds.
Disclaimer: This product is sold strictly for laboratory research use only. It is not intended for diagnostic, therapeutic, or human consumption.





Reviews
There are no reviews yet.